These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 32070160)
41. Voltage-Gated Ion Channels in the PNS: Novel Therapies for Neuropathic Pain? Tibbs GR; Posson DJ; Goldstein PA Trends Pharmacol Sci; 2016 Jul; 37(7):522-542. PubMed ID: 27233519 [TBL] [Abstract][Full Text] [Related]
42. Structure and activity relationship in the (S)-N-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockers. Kers I; Csjernyik G; Macsari I; Nylöf M; Sandberg L; Skogholm K; Bueters T; Eriksson AB; Oerther S; Lund PE; Venyike E; Nyström JE; Besidski Y Bioorg Med Chem Lett; 2012 Sep; 22(17):5618-24. PubMed ID: 22832315 [TBL] [Abstract][Full Text] [Related]
43. Neural tissue engineering scaffold with sustained RAPA release relieves neuropathic pain in rats. Ding T; Zhu C; Kou ZZ; Yin JB; Zhang T; Lu YC; Wang LY; Luo ZJ; Li YQ Life Sci; 2014 Sep; 112(1-2):22-32. PubMed ID: 25050464 [TBL] [Abstract][Full Text] [Related]
44. Voltage gated sodium channel inhibitors as anticonvulsant drugs: A systematic review on recent developments and structure activity relationship studies. Pal R; Kumar B; Akhtar MJ; Chawla PA Bioorg Chem; 2021 Oct; 115():105230. PubMed ID: 34416507 [TBL] [Abstract][Full Text] [Related]
45. Ion channel blockers for the treatment of neuropathic pain. Colombo E; Francisconi S; Faravelli L; Izzo E; Pevarello P Future Med Chem; 2010 May; 2(5):803-42. PubMed ID: 21426204 [TBL] [Abstract][Full Text] [Related]
46. Emerging therapies in clinical development and new contributions for neuropathic pain. Alcántara Montero A; Sánchez Carnerero CI; Goicoechea García C Rev Esp Anestesiol Reanim (Engl Ed); 2019; 66(6):324-334. PubMed ID: 31010688 [TBL] [Abstract][Full Text] [Related]
47. The Role of Voltage-Gated Sodium Channels in Pain Signaling. Bennett DL; Clark AJ; Huang J; Waxman SG; Dib-Hajj SD Physiol Rev; 2019 Apr; 99(2):1079-1151. PubMed ID: 30672368 [TBL] [Abstract][Full Text] [Related]
48. Reversal of Peripheral Neuropathic Pain by the Small-Molecule Natural Product Physalin F via Block of CaV2.3 (R-Type) and CaV2.2 (N-Type) Voltage-Gated Calcium Channels. Shan Z; Cai S; Yu J; Zhang Z; Vallecillo TGM; Serafini MJ; Thomas AM; Pham NYN; Bellampalli SS; Moutal A; Zhou Y; Xu GB; Xu YM; Luo S; Patek M; Streicher JM; Gunatilaka AAL; Khanna R ACS Chem Neurosci; 2019 Jun; 10(6):2939-2955. PubMed ID: 30946560 [TBL] [Abstract][Full Text] [Related]
49. Sodium Channel Na Klein AH; Vyshnevska A; Hartke TV; De Col R; Mankowski JL; Turnquist B; Bosmans F; Reeh PW; Schmelz M; Carr RW; Ringkamp M J Neurosci; 2017 May; 37(20):5204-5214. PubMed ID: 28450535 [TBL] [Abstract][Full Text] [Related]
50. Spider Knottin Pharmacology at Voltage-Gated Sodium Channels and Their Potential to Modulate Pain Pathways. Dongol Y; Cardoso FC; Lewis RJ Toxins (Basel); 2019 Oct; 11(11):. PubMed ID: 31671792 [TBL] [Abstract][Full Text] [Related]
51. Synthesis and Evaluation of Novel α-Aminoamides Containing an Indole Moiety for the Treatment of Neuropathic Pain. Li H; Fan S; Cheng J; Zhang P; Zhong B; Shi W Molecules; 2016 Jun; 21(7):. PubMed ID: 27347907 [TBL] [Abstract][Full Text] [Related]
52. HYP-1, a novel diamide compound, relieves inflammatory and neuropathic pain in rats. Kam YL; Back SK; Kang B; Kim YY; Kim HJ; Rhim H; Nah SY; Chung JM; Kim DH; Choi JS; Na HS; Choo HY Pharmacol Biochem Behav; 2012 Nov; 103(1):33-42. PubMed ID: 22867799 [TBL] [Abstract][Full Text] [Related]